Unpacking the legal challenges in sourcing AI in healthcare and life sciences in the US and the EU Webinar Series
Speakers
With the rapid rise in popularity of AI across various sectors, particularly in drug development and healthcare, law departments are initially tasked with structuring sourcing activities to establish appropriate purchasing or deployment terms and governance for new AI models and systems. Over the course of two webinars, Bird & Bird and Epstein Becker & Green will offer practical guidance and tips for the industry. The programme for both webinars is detailed below.
Programme
Monday 17 June 2024
11AM EDT / 4PM BST / 5PM CEST
| 11:00 - 11:20 | Transaction support and best practices in contracting provisions for the acquisition or deployment of machine learning models |
| 11:20 - 11:40 | Intellectual property support and training data support, as these licensing deals are rife with IP issues |
| 11:40 - 12:00 | Privacy and security, finding a way to comply with wide-ranging requirements at the international, national and state and local realms |
Friday 21 June 2024
11AM EDT / 4PM BST / 5PM CEST
| 11:00 - 11:20 |
Due diligence considerations
|
| 11:20 - 11:40 |
AI – Data Ethics Issues
|
| 11:40 - 12:00 |
Regulatory compliance issues in the healthcare sector
|